Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Optic axis uniformity as a metric to improve the contrast of birefringent structures and analyze the retinal nerve fiber layer in polarization-sensitive optical coherence tomography.

Willemse J, Gräfe MGO, van de Kreeke JA, Feroldi F, Verbraak FD, de Boer JF.

Opt Lett. 2019 Aug 1;44(15):3893-3896. doi: 10.1364/OL.44.003893.

PMID:
31368995
2.

Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer's disease.

den Haan J, Csinscik L, Parker T, Paterson RW, Slattery CF, Foulkes A, Bouwman FH, Verbraak FD, Scheltens P, Peto T, Lengyel I, Schott JM, Crutch SJ, Shakespeare TJ, Yong KXX.

Alzheimers Res Ther. 2019 Jul 18;11(1):62. doi: 10.1186/s13195-019-0516-x.

3.

Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease.

Haan JD, van de Kreeke JA, Konijnenberg E, Kate MT, Braber AD, Barkhof F, van Berckel BN, Teunissen CE, Scheltens P, Visser PJ, Verbraak FD, Bouwman FH.

Alzheimers Dement (Amst). 2019 Jun 18;11:463-471. doi: 10.1016/j.dadm.2019.05.002. eCollection 2019 Dec.

4.

Quality factor based correction for SD-OCT measurements in cataract patients.

Darma S, van den Berg TJTP, Kok PHB, Hulsman CA, Mourits MP, Schlingemann RO, Verbraak FD.

Acta Ophthalmol. 2019 Jun 18. doi: 10.1111/aos.14153. [Epub ahead of print]

PMID:
31210009
5.

Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease?

Haan JD, van de Kreeke JA, van Berckel BN, Barkhof F, Teunissen CE, Scheltens P, Verbraak FD, Bouwman FH.

Alzheimers Dement (Amst). 2019 May 10;11:383-391. doi: 10.1016/j.dadm.2019.03.006. eCollection 2019 Dec.

6.

Retinal layer thickness in preclinical Alzheimer's disease.

van de Kreeke JA, Nguyen HT, den Haan J, Konijnenberg E, Tomassen J, den Braber A, Ten Kate M, Collij L, Yaqub M, van Berckel B, Lammertsma AA, Boomsma DI, Tan HS, Verbraak FD, Visser PJ.

Acta Ophthalmol. 2019 May 6. doi: 10.1111/aos.14121. [Epub ahead of print]

PMID:
31058465
7.

Diagnostic Accuracy of a Device for the Automated Detection of Diabetic Retinopathy in a Primary Care Setting.

Verbraak FD, Abramoff MD, Bausch GCF, Klaver C, Nijpels G, Schlingemann RO, van der Heijden AA.

Diabetes Care. 2019 Apr;42(4):651-656. doi: 10.2337/dc18-0148. Epub 2019 Feb 14.

PMID:
30765436
8.

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer's disease retinas.

den Haan J, Morrema THJ, Verbraak FD, de Boer JF, Scheltens P, Rozemuller AJ, Bergen AAB, Bouwman FH, Hoozemans JJ.

Acta Neuropathol Commun. 2018 Dec 28;6(1):147. doi: 10.1186/s40478-018-0650-x.

9.

Retinal and Cerebral Microvasculopathy: Relationships and Their Genetic Contributions.

van de Kreeke JA, Nguyen HT, Konijnenberg E, Tomassen J, den Braber A, Ten Kate M, Sudre CH, Barkhof F, Boomsma DI, Tan HS, Verbraak FD, Visser PJ.

Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):5025-5031. doi: 10.1167/iovs.18-25341.

PMID:
30326071
10.

Achieving balance in the treatment and monitoring of neovascular age-related macular degeneration in the real world: lessons from the Netherlands cohort of the AURA study.

van Asten F, de Jong-Hesse Y, van Lith-Verhoeven JJC, Verbraak FD, Vromans JGF, Lau NC, Altemark A, Hoyng CB.

Acta Ophthalmol. 2019 Mar;97(2):e323-e324. doi: 10.1111/aos.13946. Epub 2018 Oct 14. No abstract available.

PMID:
30318723
11.

The EMIF-AD PreclinAD study: study design and baseline cohort overview.

Konijnenberg E, Carter SF, Ten Kate M, den Braber A, Tomassen J, Amadi C, Wesselman L, Nguyen HT, van de Kreeke JA, Yaqub M, Demuru M, Mulder SD, Hillebrand A, Bouwman FH, Teunissen CE, Serné EH, Moll AC, Verbraak FD, Hinz R, Pendleton N, Lammertsma AA, van Berckel BNM, Barkhof F, Boomsma DI, Scheltens P, Herholz K, Visser PJ.

Alzheimers Res Ther. 2018 Aug 4;10(1):75. doi: 10.1186/s13195-018-0406-7.

12.

Outcomes and complications of Baerveldt glaucoma drainage implants for the treatment of uveitis-related glaucoma.

Diederen RM, Hulsman CA, Zegers RH, Verbraak FD.

Acta Ophthalmol. 2018 Sep;96(6):e752-e753. doi: 10.1111/aos.13679. Epub 2018 Jan 19. No abstract available.

PMID:
29350790
13.

Retinal thickness correlates with parietal cortical atrophy in early-onset Alzheimer's disease and controls.

den Haan J, Janssen SF, van de Kreeke JA, Scheltens P, Verbraak FD, Bouwman FH.

Alzheimers Dement (Amst). 2017 Nov 6;10:49-55. doi: 10.1016/j.dadm.2017.10.005. eCollection 2018.

14.

Inflammatory and Neuronal Biomarkers Associated With Retinal Thinning in Pediatric HIV.

Blokhuis C, Doeleman S, Cohen S, Demirkaya N, Scherpbier HJ, Kootstra NA, Kuhle J, Teunissen CE, Verbraak FD, Pajkrt D.

Invest Ophthalmol Vis Sci. 2017 Nov 1;58(13):5985-5992. doi: 10.1167/iovs.17-22252.

PMID:
29183044
15.

Economic evaluation of an e-mental health intervention for patients with retinal exudative diseases who receive intraocular anti-VEGF injections (E-PsEYE): protocol for a randomised controlled trial.

van der Aa HPA, van Rens GHMB, Verbraak FD, Bosscha M, Koopmanschap MA, Comijs HC, Cuijpers P, van Nispen RMA.

BMJ Open. 2017 Nov 15;7(11):e018149. doi: 10.1136/bmjopen-2017-018149.

16.

Ganglion cell layer measurements correlate with disease severity in patients with Alzheimer's disease.

den Haan J, Balk LJ, Verbraak FD.

Acta Ophthalmol. 2018 Mar;96(2):e265-e266. doi: 10.1111/aos.13550. Epub 2017 Aug 22. No abstract available.

17.

PREDICTIVE VALUE OF OPTICAL COHERENCE TOMOGRAPHIC FEATURES IN THE BEVACIZUMAB AND RANIBIZUMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA (BRDME) STUDY.

Fickweiler W, Schauwvlieghe AME, Schlingemann RO, Maria Hooymans JM, Los LI, Verbraak FD; BRDME Research Group.

Retina. 2018 Apr;38(4):812-819. doi: 10.1097/IAE.0000000000001626.

PMID:
28406860
18.

Retinal thickness in Alzheimer's disease: A systematic review and meta-analysis.

den Haan J, Verbraak FD, Visser PJ, Bouwman FH.

Alzheimers Dement (Amst). 2017 Jan 25;6:162-170. doi: 10.1016/j.dadm.2016.12.014. eCollection 2017.

19.

The Eye as a Window to the Brain: Neuroretinal Thickness Is Associated With Microstructural White Matter Injury in HIV-Infected Children.

Blokhuis C, Demirkaya N, Cohen S, Wit FW, Scherpbier HJ, Reiss P, Abramoff MD, Caan MW, Majoie CB, Verbraak FD, Pajkrt D.

Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3864-71. doi: 10.1167/iovs.16-19716.

PMID:
27447087
20.

Retinal blood flow is increased in type 1 diabetes mellitus patients with advanced stages of retinopathy.

Nguyen HT, van Duinkerken E, Verbraak FD, Polak BC, Ringens PJ, Diamant M, Moll AC.

BMC Endocr Disord. 2016 May 26;16(1):25. doi: 10.1186/s12902-016-0105-y.

21.

Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study.

Schauwvlieghe AM, Dijkman G, Hooymans JM, Verbraak FD, Hoyng CB, Dijkgraaf MG, Peto T, Vingerling JR, Schlingemann RO.

PLoS One. 2016 May 20;11(5):e0153052. doi: 10.1371/journal.pone.0153052. eCollection 2016.

22.

Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus.

Sohn EH, van Dijk HW, Jiao C, Kok PH, Jeong W, Demirkaya N, Garmager A, Wit F, Kucukevcilioglu M, van Velthoven ME, DeVries JH, Mullins RF, Kuehn MH, Schlingemann RO, Sonka M, Verbraak FD, Abràmoff MD.

Proc Natl Acad Sci U S A. 2016 May 10;113(19):E2655-64. doi: 10.1073/pnas.1522014113. Epub 2016 Apr 25.

23.

HIV-Associated Neuroretinal Disorder in Patients With Well-Suppressed HIV-Infection: A Comparative Cohort Study.

Demirkaya N, Wit FW, van Den Berg TJ, Kooij KW, Prins M, Schlingemann RO, Abramoff MD, Reiss P, Verbraak FD; AGEhIV Cohort Study Group.

Invest Ophthalmol Vis Sci. 2016 Mar;57(3):1388-97. doi: 10.1167/iovs.15-18537.

PMID:
27018841
24.

Relevance of Retinal Thickness Changes in the OCT Inner and Outer Rings to Predict Progression to Clinical Macular Edema: An Attempt of Composite Grading of Macular Edema.

Vujosevic S, Varano M, Egan C, Sivaprasad S, Menon G, Erginay A, Verbraak FD, Lund-Andersen H, Martinez JP, Jürgens I, Smets E, Coriat C, Wiedemann P, Ágoas V, Querques G, Holz FG, Nunes S, Alves D, Neves C, Santos T, Ribeiro L, Bandello F, Tejerina AN, Cunha-Vaz J; EVICR.net.

Ophthalmic Res. 2015;55(1):19-25. doi: 10.1159/000441110. Epub 2015 Nov 6.

PMID:
26555067
25.

Characterization of Retinal Disease Progression in a 1-Year Longitudinal Study of Eyes With Mild Nonproliferative Retinopathy in Diabetes Type 2.

Ribeiro L, Bandello F, Tejerina AN, Vujosevic S, Varano M, Egan C, Sivaprasad S, Menon G, Massin P, Verbraak FD, Lund-Andersen H, Martinez JP, Jürgens I, Smets E, Coriat C, Wiedemann P, Ágoas V, Querques G, Holz FG, Nunes S, Neves C, Cunha-Vaz J; Evicr Net Study Group.

Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5698-705. doi: 10.1167/iovs.15-16708.

PMID:
26322834
26.

One-year progression of diabetic subclinical macular edema in eyes with mild nonproliferative diabetic retinopathy: location of the increase in retinal thickness.

Tejerina AN, Vujosevic S, Varano M, Egan C, Sivaprasad S, Menon G, Massin P, Verbraak FD, Lund-Andersen H, Martinez JP, Jurgens I, Smets E, Coriat C, Wiedemann P, Ágoas V, Querques G, Holz FG, Nunes S, Alves D, Neves C, Santos T, Ribeiro L, Bandello F, Cunha-Vaz J; for EVICR.net.

Ophthalmic Res. 2015;54(3):118-23. doi: 10.1159/000438793. Epub 2015 Aug 21.

PMID:
26315560
27.

Retinal layer location of increased retinal thickness in eyes with subclinical and clinical macular edema in diabetes type 2.

Bandello F, Tejerina AN, Vujosevic S, Varano M, Egan C, Sivaprasad S, Menon G, Massin P, Verbraak FD, Lund-Andersen H, Martinez JP, Jürgens I, Smets RM, Coriat C, Wiedemann P, Ágoas V, Querques G, Holz FG, Nunes S, Alves D, Neves C, Santos T, Ribeiro L, Cunha-Vaz J; EVICR.net.

Ophthalmic Res. 2015;54(3):112-7. doi: 10.1159/000438792. Epub 2015 Aug 21.

PMID:
26315448
28.

Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study).

Schauwvlieghe AM, Dijkman G, Hooymans JM, Verbraak FD, Hoyng CB, Dijkgraaf MG, Van Leeuwen R, Vingerling JR, Moll AC, Schlingemann RO.

BMC Ophthalmol. 2015 Jul 7;15:71. doi: 10.1186/s12886-015-0043-x.

29.

Retinal Structure and Function in Perinatally HIV-Infected and cART-Treated Children: A Matched Case-Control Study.

Demirkaya N, Cohen S, Wit FW, Abramoff MD, Schlingemann RO, Kuijpers TW, Reiss P, Pajkrt D, Verbraak FD.

Invest Ophthalmol Vis Sci. 2015 Jun;56(6):3945-54. doi: 10.1167/iovs.15-16855.

PMID:
26087360
30.

Systematic review of the association between Alzheimer's disease and chronic glaucoma.

Janssen SF, Jansonius NM, Bouwman F, Verbraak FD, Bergen AA.

Clin Ophthalmol. 2015 May 4;9:783-4. doi: 10.2147/OPTH.S83197. eCollection 2015. No abstract available.

31.

Detecting signs of retinal leakage in exudative AMD using Cirrus OCT versus SL SCAN-1, a novel integrated FD-OCT into a common slit lamp.

Stehouwer M, Verbraak FD, Schlingemann RO, van Leeuwen TG.

Graefes Arch Clin Exp Ophthalmol. 2016 Jan;254(1):37-41. doi: 10.1007/s00417-015-2997-z. Epub 2015 Apr 23.

32.

The quality and usability of smartphone and hand-held fundus photography, compared to standard fundus photography.

Darma S, Zantvoord F, Verbraak FD.

Acta Ophthalmol. 2015 Jun;93(4):e310-1. doi: 10.1111/aos.12632. Epub 2014 Dec 21. No abstract available.

33.

Optical density filters modeling media opacities cause decreased SD-OCT retinal layer thickness measurements with inter- and intra-individual variation.

Darma S, Kok PH, van den Berg TJ, Abràmoff MD, Faber DJ, Hulsman CA, Zantvoord F, Mourits MP, Schlingemann RO, Verbraak FD.

Acta Ophthalmol. 2015 Jun;93(4):355-61. doi: 10.1111/aos.12596. Epub 2014 Dec 8.

34.

Neuroretinal degeneration in relation to vasculopathy in diabetes.

Verbraak FD.

Diabetes. 2014 Nov;63(11):3590-2. doi: 10.2337/db14-0888. No abstract available.

35.

Recent advances in ophthalmic molecular imaging.

Ramos de Carvalho JE, Verbraak FD, Aalders MC, van Noorden CJ, Schlingemann RO.

Surv Ophthalmol. 2014 Jul-Aug;59(4):393-413. doi: 10.1016/j.survophthal.2013.09.005. Epub 2013 Oct 3. Review.

PMID:
24529711
36.

Anomalous relation between axial length and retinal thickness in amblyopic children.

Kok PH, de Kinkelder R, Braaksma-Besselink YC, Kalkman J, Prick LJ, Sminia ML, Mourits MP, Verbraak FD.

J AAPOS. 2013 Dec;17(6):598-602. doi: 10.1016/j.jaapos.2013.09.005.

PMID:
24321424
37.

Standardised disturbance of the optical coherence tomography signal has varying effects on the scan quality assessment when comparing four devices.

Kok PH, van Dijk HW, Stehouwer M, van den Berg TJ, Schlingemann RO, Verbraak FD.

Br J Ophthalmol. 2013 Nov;97(11):1484-5. doi: 10.1136/bjophthalmol-2013-303849. Epub 2013 Aug 21. No abstract available.

PMID:
23966374
38.

Senile retinoschisis versus retinal detachment, the additional value of peripheral retinal OCT scans (SL SCAN-1, Topcon).

Stehouwer M, Tan SH, van Leeuwen TG, Verbraak FD.

Acta Ophthalmol. 2014 May;92(3):221-7. doi: 10.1111/aos.12121. Epub 2013 Jun 15.

39.

Effect of age on individual retinal layer thickness in normal eyes as measured with spectral-domain optical coherence tomography.

Demirkaya N, van Dijk HW, van Schuppen SM, Abràmoff MD, Garvin MK, Sonka M, Schlingemann RO, Verbraak FD.

Invest Ophthalmol Vis Sci. 2013 Jul 22;54(7):4934-40. doi: 10.1167/iovs.13-11913.

40.

The relationship between the optical density of cataract and its influence on retinal nerve fibre layer thickness measured with spectral domain optical coherence tomography.

Kok PH, van den Berg TJ, van Dijk HW, Stehouwer M, van der Meulen IJ, Mourits MP, Verbraak FD.

Acta Ophthalmol. 2013 Aug;91(5):418-24. doi: 10.1111/j.1755-3768.2012.02514.x. Epub 2012 Oct 26.

41.

Variability in photocoagulation treatment of diabetic macular oedema.

van Dijk HW, Verbraak FD, Kok PH, Oberstein SY, Schlingemann RO, Russell SR, Abràmoff MD.

Acta Ophthalmol. 2013 Dec;91(8):722-7. doi: 10.1111/j.1755-3768.2012.02524.x. Epub 2012 Sep 13.

42.

Detection of early-stage age related macular degeneration with a compact rarebit test.

de Kinkelder R, van Leeuwen TG, Verbraak FD.

Br J Ophthalmol. 2012 Oct;96(10):1354-5. Epub 2012 Aug 3. No abstract available.

PMID:
22863947
43.

Comparison of retinal nerve fiber layer thickness measurements by spectral-domain optical coherence tomography systems using a phantom eye model.

de Kinkelder R, de Bruin DM, Verbraak FD, van Leeuwen TG, Faber DJ.

J Biophotonics. 2013 Apr;6(4):314-20. doi: 10.1002/jbio.201200018. Epub 2012 Jul 19.

PMID:
22810965
44.

Early neurodegeneration in the retina of type 2 diabetic patients.

van Dijk HW, Verbraak FD, Kok PH, Stehouwer M, Garvin MK, Sonka M, DeVries JH, Schlingemann RO, Abràmoff MD.

Invest Ophthalmol Vis Sci. 2012 May 14;53(6):2715-9. doi: 10.1167/iovs.11-8997.

45.

Heartbeat-induced axial motion artifacts in optical coherence tomography measurements of the retina.

de Kinkelder R, Kalkman J, Faber DJ, Schraa O, Kok PH, Verbraak FD, van Leeuwen TG.

Invest Ophthalmol Vis Sci. 2011 Jun 1;52(6):3908-13. doi: 10.1167/iovs.10-6738.

PMID:
21467182
46.

Scanning beyond the limits of standard OCT with a Fourier domain optical coherence tomography integrated into a slit lamp: the SL SCAN-1.

Stehouwer M, Verbraak FD, de Vries HR, van Leeuwen TG.

Eye (Lond). 2011 Jan;25(1):97-104. doi: 10.1038/eye.2010.162. Epub 2010 Nov 12.

47.

Association of visual function and ganglion cell layer thickness in patients with diabetes mellitus type 1 and no or minimal diabetic retinopathy.

van Dijk HW, Verbraak FD, Stehouwer M, Kok PH, Garvin MK, Sonka M, DeVries JH, Schlingemann RO, Abràmoff MD.

Vision Res. 2011 Jan 28;51(2):224-8. doi: 10.1016/j.visres.2010.08.024. Epub 2010 Aug 27.

48.

Antivascular endothelial growth factor treatment in pseudoxanthoma elasticum patients.

Verbraak FD.

Dev Ophthalmol. 2010;46:96-106. doi: 10.1159/000320012. Epub 2010 Aug 10.

PMID:
20703035
49.

Antivascular endothelial growth factors for inflammatory chorioretinal disorders.

Battaglia Parodi M, Iacono P, Verbraak FD, Bandello F.

Dev Ophthalmol. 2010;46:84-95. doi: 10.1159/000320011. Epub 2010 Aug 10.

PMID:
20703034
50.

Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes.

van Dijk HW, Verbraak FD, Kok PH, Garvin MK, Sonka M, Lee K, Devries JH, Michels RP, van Velthoven ME, Schlingemann RO, Abràmoff MD.

Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3660-5. doi: 10.1167/iovs.09-5041. Epub 2010 Feb 3.

Supplemental Content

Loading ...
Support Center